Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-19-038494

Chief Executive Officer sold 39,636 shares at an average $44.20 ($1,752,006)

  • Chief Executive Officer acquired 13,668 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Neff Thomas B · Chief Executive Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-19 Exercise or conversion : show line 1 in the form +6,834 $2.90 $19,819 2,449,106 D
2019-06-19 Sale : show line 2 in the form −18,400 $44.02 $809,968 2,430,706 D
2019-06-19 Sale : show line 3 in the form −1,418 $43.99 $62,378 57,000 I
2019-06-20 Exercise or conversion : show line 4 in the form +6,834 $2.90 $19,819 2,437,540 D
2019-06-20 Sale : show line 5 in the form −16,200 $44.28 $717,336 2,421,340 D
2019-06-20 Sale : show line 6 in the form −2,200 $45.22 $99,484 2,419,140 D
2019-06-20 Sale : show line 7 in the form −1,318 $44.23 $58,295 55,682 I
2019-06-20 Sale : show line 8 in the form −100 $45.45 $4,545 55,582 I
Open-market sales · 39,636 sh · avg $44.20 · $1,752,006

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-06-19 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −6,834 $2.90 2020-06-09 6,834 239,208 D
2019-06-20 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −6,834 $2.90 2020-06-09 6,834 232,374 D
Loading xslF345X03/doc4.xml…